Emergent BioSolutions EBS
NYSE EBS
$6.76 +0.21 (+3.21%)
At close: Sep 22, 2026 · 4:00 PM EDT

Emergent BioSolutions (EBS) Cash & Equivalents Growth (3y) (2013 - 2026)

Analysis

Emergent BioSolutions (EBS) Cash & Equivalents Growth (3y) (2013 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. Growth (3y) (Qtr)
1 Johnson & Johnson 649.47 Bn 628.71 Bn 17.26 Bn -1.21%
2 AbbVie 467.46 Bn 460.93 Bn 12.70 Bn -9.15%
3 Merck 369.31 Bn 362.22 Bn 12.21 Bn 6.56%
4 Novartis Ag 269.03 Bn 261.74 Bn 11.24 Bn -11.22%
5 Pfizer 158.11 Bn 146.71 Bn 10.94 Bn -28.16%
6 Bristol Myers Squibb 127.96 Bn 116.89 Bn 9.25 Bn 1.37%
7 Sanofi 51.83 Bn 44.86 Bn 10.79 Bn -5.35%
8 BeOne Medicines 41.33 Bn 36.23 Bn 1.53 Bn 14.34%
9 Revolution Medicines 41.30 Bn 41.30 Bn - -
10 Emergent BioSolutions 335.50 Mn 194.60 Mn 137.20 Mn 16.39%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 16.39%
Mar 31, 2026 -28.04%
Dec 31, 2025 -31.63%
Sep 30, 2025 0.63%
Jun 30, 2025 -9.29%
Mar 31, 2025 -30.06%
Dec 31, 2024 -44.31%
Sep 30, 2024 -28.13%
Jun 30, 2024 -46.20%
Mar 31, 2024 -47.67%
Dec 31, 2023 -43.56%
Sep 30, 2023 -40.41%
Jun 30, 2023 -30.92%
Mar 31, 2023 33.33%
Dec 31, 2022 56.45%
Sep 30, 2022 20.06%
Jun 30, 2022 26.38%
Mar 31, 2022 47.00%
Dec 31, 2021 72.52%
Sep 30, 2021 5.97%
API Access

Emergent BioSolutions Cash & Equivalents Growth (3y) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-equivalents-growth-3y&ticker=EBS&period=max&api_key=YOUR_API_KEY